Market News
-
Samsung is investing in effective medical solutions tailored for South Africa
Posted on :Wednesday , 10th December 2014
Samsung Electronics South Africa has invested significantly into the medical sector, with the aim of using the latest in technological innovation to assist in delivering transformational change in the health sector in Africa.Through its Health and Medical Equipment portfolio, Samsung has developed market-leading solutions in areas including Digital Radiology, Ultrasound and IVD (in-vitro diagno. . .
Kenya: Karen Hospital Installs Philips\' Ingenia Digital Broadband MRI System
Posted on :Wednesday , 10th December 2014
Philips East Africa and the Diagnostic Imaging Department at Karen Hospital have inaugurated the Philips Ingenia 3.0T MRI, billed as the first-ever digital broadband magnetic resonance imaging (MRI) solution.Driven by Philips’ commitment to developing innovative patient care solutions, the Ingenia MR delivers exceptional image clarity, scanning efficiency and scalability. Karen Hospital h. . .
$20m pharmaceuticals warehouse built in Kenya
Posted on :Thursday , 4th December 2014
Logistics company Imperial Logistics’ Africa-focused healthcare supply chain management provider last month started the construction of a $20- million pharmaceuticals storage and distribution facility in Nairobi, Kenya.
Imperial Health Sciences MD Dr Iain Barton states that the project started on September 15 and is scheduled for completion in October and to b. . .Intravenous fluids plant opened in Sudan
Posted on :Thursday , 4th December 2014
A $25 million intravenous fluids plant was officially opened this month in Sudan by Vice President Hassabo Mohamed Abdul-Rahman.
The plant, which has been ready for production for the past seven years, had faced operational delays owing to differences with the Malaysian partner and has capacity to produce 8 million units of intravenous fluids and 700,000 units of so. . .Pharco to develop Presidio\'s NS5A inhibitor PPI-668 for HCV in Kenya
Posted on :Thursday , 4th December 2014
Pharco Pharmaceuticals has entered into an exclusive license agreement to develop and commercialize Presidio’s clinical stage hepatitis C virus (HCV) NS5A inhibitor PPI-668 in Kenya.
With the exclusive license, Pharco will now be able to expand its licensed territory to one or more additional countries in the Middle East and East Africa region.&nb. . .Please Select an Option
Expogroup
Expogroup is a full service exhibition organiser with over 29 years experience in International trade exhibitions. Our current portfolio includes 25 annual exhibitions from a diverse range of industries being held across the Middle East & Africa.
EXPOGROUP © 1996 - 2026 | Privacy policyFacebook
Links
